Related Experiment Videos
Loss of heterozygosity and the origin of meningioma
1Institut für Humangenetik der Universität, Homburg/Saar, Federal Republic of Germany.
Abstract:
In some human tumors, loss of particular genes manifested indirectly by loss of heterozygosity for specific RFLPs seems to uncover either heterozygous deletions leading to a gene doses effect or homozygous deletions due to a silent allele at the corresponding locus, both causing the loss of regulatory functions (antioncogenes, suppressor genes). Meningioma, a benign human tumor derived from the coverings of brain and spinal cord, is associated with complete loss, rarely deletion, of one chromosome 22. About 60% of meningiomas exhibit monosomy 22 in all or part of cells; however, about 40% display a normal karyotype. Comparison of constitutional and tumor genomes from 12 patients showed loss of heterozygosity on 22 in three cases, suggesting the involvement of events at the DNA level.
Insights
Gene deletions in human tumors can lead to loss of regulatory functions. Meningiomas, brain tumors, often involve chromosome 22 abnormalities, suggesting DNA-level events.
Area of Science:
- Oncology
- Human Genetics
- Molecular Biology
Background:
- Gene deletions can result in loss of regulatory functions, impacting tumor development.
- Meningiomas, benign tumors of the brain and spinal cord coverings, are frequently associated with chromosome 22 abnormalities.
- While 60% of meningiomas show monosomy 22, 40% present a normal karyotype, indicating varied genetic mechanisms.
Purpose of the Study:
- To investigate the role of DNA-level events in meningioma development.
- To identify potential tumor suppressor genes or regulatory genes on chromosome 22 involved in meningioma pathogenesis.
Main Methods:
- Comparative analysis of constitutional and tumor genomes from 12 meningioma patients.
- Loss of heterozygosity (LOH) analysis for specific restriction fragment length polymorphisms (RFLPs) on chromosome 22.
Main Results:
- Loss of heterozygosity on chromosome 22 was detected in three out of 12 meningioma cases.
- These findings suggest that DNA-level alterations, beyond complete chromosome loss, contribute to meningioma formation.
- The observed LOH indicates the potential involvement of tumor suppressor genes or regulatory elements on chromosome 22.
Conclusions:
- DNA-level events, including loss of heterozygosity, play a role in the development of meningiomas.
- Further investigation into specific genes on chromosome 22 is warranted to understand their function as antioncogenes or suppressor genes in meningioma pathogenesis.